Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06213701 · ClinicalTrials.gov registry record · NA

Behavior, Biology and Well-Being Study

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
300
Enrollment target

NCT06213701: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT06213701 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06213701, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

The central aim of this pilot study is to compare markers of inflammation and gut microbial diversity with users of the Healthy Minds Program (HMP) app, an intervention designed to promote well-being. The investigators plan to conduct a randomized controlled trial (RCT) involving 300 participants comparing 4-weeks of the HMP app with an active control (Psychoeducation \[HMP without meditation practice\]), and a waitlist control in a sample of United States adults with elevated depression symptoms.

Primary Outcome

Feasibility is defined as 80% of participants providing samples at both time points (completer n = 240) with no differences in completion rates between non-Hispanic White and racial/ethnic minority participants.

Interventions

  • DEVICE Healthy Minds Program
  • OTHER Psychoeducation app

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-06-16
Est. Completion 2023-07-15
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT06213701 record still lists

NCT06213701 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 2 interventions - of which Healthy Minds Program is the first listed.

NCT06213701 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06213701 about?

NCT06213701 is a clinical study titled "Behavior, Biology and Well-Being Study". The central aim of this pilot study is to compare markers of inflammation and gut microbial diversity with users of the Healthy Minds Program (HMP) app, an intervention designed to promote well-being. The investigators plan to conduct a randomized controlled trial (RCT) involving 300 participants co...

What is the current status of trial NCT06213701?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2022-06-16. Estimated completion is 2023-07-15.

What interventions are being tested in trial NCT06213701?

The interventions under investigation include: Healthy Minds Program (DEVICE), Psychoeducation app (OTHER).

Who is sponsoring clinical trial NCT06213701?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06213701's enrollment target sits among peer trials

300 330th of 2000 higher than 1,630 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06213701, the US trial registry maintained by the National Library of Medicine. NCT06213701 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.